The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Krista Nelson received Leadership in Oncology Social Work Award

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Krista Nelson was awarded the Association of Oncology Social Work’s 2019 Leadership in Oncology Social Work Award.

Nelson serves as secretary of the Association of Community Cancer Centers, program manager of Quality & Research, Cancer Support Services & Compassion, Providence Cancer Institute, Providence Health and Services in Portland, OR.

The award was conferred during the AOSW 35th Annual Conference.

Nelson is a past president of the board of directors of the Association of Oncology Social Work. She is also a past invited director of the American Psychosocial Oncology Society. She serves as an invited director on the board of directors of the National Accreditation Program for Breast Centers and as a director of the American Clinical Social Work Association. In 2015, Nelson was named as a finalist in the Schwartz Center Compassionate Caregiver of the Year Award.

In presenting the award, Leora Lowenthal, AOSW Awards committee member, recognized Nelson for her leadership and strength in fostering partnerships across the wider oncology community.

The Leader in Oncology Social Work Award is sponsored by the American Cancer Society.

Table of Contents

YOU MAY BE INTERESTED IN

ClinicalTrials & Tribulations

Saving Western Kenya’s pediatric blood cancer patients
How flow cytometry is changing the diagnostic landscape

When our hematological malignancy testing pilot project began in Eldoret, Kenya, there seemed to be a mismatch in relation to progress in healthcare. The region, like much of sub-Saharan Africa, had been focusing on combatting infectious diseases such as HIV and malaria—which was much-needed—yet cancer care was under-resourced. 
By Samuel (Tony) Boova, Eda Holl, LaToya Montgomery, Steve Kussick, Nicholas Kigen, Gilbert Olbara, Festus Muigai Njuguna, Terry Vik and Teresa Loile Lotodo
ClinicalTrials & Tribulations

The challenge of making the move from conversational AI to autonomous scientific discovery
Advancing from level II to level III AI agents in precision medicine

Artificial intelligence is rapidly transforming biomedical research and healthcare. Large language models, foundation models, and AI agents are increasingly being deployed to assist with data interpretation, literature review, clinical decision support, and translational research. 
By Enrique Velazquez-Villarreal
Sponsored

The long life of a clinical trial
How JCO sustains landmark oncology research

In modern oncology, important insights from clinical trials often emerge years after initial publication. As new therapies extend survival and transition more patients into long-term remissions, clinicians and researchers are increasingly looking beyond initial response rates to understand durability, long-term safety, and even the possibility of a cure. 
By Journal of Clinical Oncology
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account